Le Lézard
Classified in: Health, Business

New Protection Plan Gives Breast Implant Patients Peace of Mind Long After Surgery


DALLAS, Sept. 21, 2018 /PRNewswire-PRWeb/ -- Women who undergo breast implant surgery naturally want a beautiful, worry-free outcome. However, the implant manufacturer's warranty does not always protect them against uninsured expenses for unexpected complications. Women can now elect low-cost, extensive protection for their breast augmentation with the IDEAL IMPLANT Premium Protection Plan for greater peace of mind if an issue should arise, and the plan is renewable for life.

This first-of-its-kind breast implant protection plan provides women with financial assistance for uninsured expenses of early complications that may include bleeding, infection, anesthesia, blood clots and wound healing events, as well as late complications such as deflation, capsular contracture and scar revision. Women enroll with their surgeon prior to the procedure for a one-time payment of $189 for primary breast augmentation or $249 if exchanging existing implants. Continuing protection costs $79 a year.

The IDEAL IMPLANT Premium Protection Plan provides financial assistance up to the limits shown:

All women receiving IDEAL IMPLANT® Structured Breast Implants receive replacement implants for life due to deflation and for 10 years due to capsular contracture. Women who do not select the Premium Protection Plan are automatically enrolled in the company's Basic Protection Plan, which provides up to $3,500 in financial assistance for deflation for 10 years.

"We feel our responsibility to women receiving our implants doesn't end when the final stitch is tied," said Dr. Robert S. Hamas, IDEAL IMPLANT inventor and board-certified plastic surgeon. "While IDEAL IMPLANT offers some of the lowest rupture and capsular contracture rates among implants, we want to provide women with financial peace of mind in case an unexpected expense arises, whether for an early post-operative complication, or a problem that arises many years in the future."

"The IDEAL IMPLANT Premium Protection Plan has benefits that go far beyond what other implant companies offer," Dr. Hamas explained. "Coupled with the already high-performing IDEAL IMPLANT, this new program is a win-win for women desiring more natural looking and feeling breast implants, with the greater peace of mind that comes from both the safety of saline inside and the expanded financial protection."

For more information, visit https://idealimplant.com/protection/.

About IDEAL IMPLANT
Ideal Implant Incorporated is a privately held company that was founded in 2006 by Robert S. Hamas, MD, the plastic surgeon who invented the IDEAL IMPLANT. After years of dealing with ruptured silicone gel implants and listening to patient concerns, Dr. Hamas realized that women wanted a new type of breast implant?one that would combine the natural feel of a silicone gel implant with only saline inside for safety and peace of mind.

The unique design of the IDEAL IMPLANT provides a natural feel and youthful look?without using silicone gel. The IDEAL IMPLANT incorporates a series of shells nested together and two separate chambers that hold saline. This patented internal structure controls movement of the saline and supports the implant edges to prevent collapse and wrinkling. IDEAL IMPLANT has undergone 10 years of development, testing, and refinement?including contributions of clinical expertise from other board-certified plastic surgeons. The IDEAL IMPLANT was approved by both the U.S. Food and Drug Administration and Health Canada in 2014.

For more information, visit https://idealimplant.com/.

 

SOURCE IDEAL IMPLANT


These press releases may also interest you

at 21:29
TSX VENTURE COMPANIES BULLETIN V2024-1211 ALPHAMIN RESOURCES CORP.  ("AFM")BULLETIN TYPE:  Declaration of DividendBULLETIN DATE:  April 26, 2024TSX Venture Tier 2 Company The Issuer has declared the following dividend: Dividend Amount per Common...

at 21:22
Wall Financial Corporation (the "Company") released its operating results and financial statements for the three months and year  ended January 31, 2024.  The Company recorded net earnings and comprehensive income attributable to shareholders of the...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 20:39
Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New...

at 20:15
The partnership was unveiled internally at the Franchisor's annual convention in Las Vegas, NV in December 2023, eliciting...

at 19:35
Regenx Tech Corp., (the "Company" or "Regenx") is providing this bi-weekly update on the status of the application to the Alberta Securities Commission for a management cease trade order, under National Policy 12-203 -?? Management Cease Trade...



News published on and distributed by: